nutrition
Home
What's New
About the Club
Become a Member
Cannabis Dispensary
Wellness Centre
Our Community
Medical Cannabis
About the Plant
Symptoms & Conditions
Safe and Effective Use
Research
Historical Records
Other Resources
Law, Politics & News
Links
Contact Us
Support Us

Research

Research can be used as a tool to allow us to use cannabis more knowledgably and effectively.

The BCCCS does not condone or endorse animal testing.

On this page you will find:

  • BCCCS Research
  • Other Research Projects of Note
  • Latest Published  Research of Note 
  • Research Resources
  • Condition and Symptom Related Research

BCCCS Research:

The BCCCS is dedicated to supporting and initiating research that is in line with our Mission, Vision and Values. All research we participate in must meet our Ethical Standards for Research. BCCCS Current Research Projects:

- Ethnographic Study of Compassion Clubs and Cannabis Use as Self-Medication - In conjuction with the BCCCS, VICS, CALM, TCC and the Center for Addiction and Mental Health.

- Mental Health Survey - A survey completed by BCCCS members regarding their use of cannabis for mental health conditions and its effect on their mental health.

BCCCS Past Research Projects:

  • Survey of medicinal cannabis use among childbearing women    - Published Jan, 2006 in Complementary Therapies in Clinical Practice. Between November 2003 and May 2004, women members of the BCCCS and the VICS filled out a questionnaire about their use of cannabis in general and more specifically during pregnancy. This questionnaire was part of a joint project between researchers at the University of BC and the University of Victoria. The results show that indeed many women successfully relieve their nausea and vomiting during pregnancy with Cannabis – over 92% of the respondents rated cannabis as ‘extremely effective’ or ‘effective’.  

  • Cannabis as Therapy for People Living with HIV/AIDS: “Our Right, Our Choice”  - June 14, 2006, The Canadian AIDS Society.  This study examined the legal, ethical and human rights issues related to access and regulation of cannabis for therapeutic purposes for people living with HIV/AIDS. The BCCCS was honoured to be a key informant in this incredible project that will benefit all those who use cannabis as a medicine. The report recommended an Auditor General review of Health Canada’s medical marijuana program, the recognition of compassion clubs as legal dispensaries of medicinal cannabis, and having the costs of cannabis covered under provincial drug plans. 
     
  • Cannabis Use and Hepatitis C Treatment Outcomes ( PDF) - Published in the European Journal of Gastroenterology and Hepatology 2006.   A researcher at the University of Berkley discovered that people using cannabis in conjunction with their interferon treatments had better success rates then those who were not using cannabis. We wanted to understand if the increased success rates were due to people being able to complete their treatments because they were managing the side effects of interferon with cannabis, or if there is a beneficial interaction between interferon and cannabis.    Many members of the BCCCS and VICS completed a survey in 2004, which helped inform this study.

     
Other Current Research Projects of Note:

  • COMPASS - Cannabis for the management of pain: assessment of safety study.  Funded by Health Canda and the Canadian Institute of Health Research
 

Latest Published Research of Note:

Research Resources:


Condition and Symptom Related Research:

 
General Information

Formalism and Narrative in Law and Medicine: The Debate Over Medical Marijuana Use

Journal of Drug Issues. 1999. 29(1): 121-134. By Desmond Manderson CONTENTS Abstract Introducing Dichotomies Formalism or Narrative Two Frameworks of Liberalism

Medical Marihuana in a Time of Prohibition

International Journal of Drug Policy 10 (1999) 145-156 By Lester Grinspoon Harvard Medical School, 74 Fenwood Road, Boston, MA 02115, USA Abstract - As the medical virtues of cannabis become increasingly clear, the question of how to make it available to patients becomes incre

Herb Remedy

Scientific American , September 1999 By Gary Stix The exact location is a secret. But somewhere between London and Brighton a compound ringed by high fences and razor wire will house the world's only pot farm primarily devoted to commercial drug development. In June the British Home Office gave

Counterblaste to the I.O.M.

International Journal of Drug Policy , November 1, 1999 By Peter Webster, vignes@monaco.mc I n mid-March of this year, the report of the U.S. Institute of Medicine (Joy et al., 1999

Cannabis as Medicine: Time for the Phoenix to Rise?

British Medical Journal, April 4, 1998 (316:1034-1035) Philip Robson, Senior Clinical Lecturer Warneford Hospital, Oxford OX3 7JX Since 1971 Brit

Marihuana as Medicine: A Plea for Reconsideration

Journal of the American Medical Association, 273.23 (June 1995): 1875-76. By Lester Grinspoon, MD and James B. Bakalar, JD

Marijuana Substitute Combats Nerve Gas

Scripps Howard News Service, January 5, 1998 By Julian Borger JERUSALEM -- The best available protection against nerve gas attack comes from an Isr

Therapeutic Possibilities in Cannabinoids

The Lancet , March 22, 1975, pp. 667-69 T o early man, Cannabis sativa L. was a source of food ( hemp seed and oil) and of fibre (ropes), though, according to mytholog

Federal Foolishness and Marijuana

New England Journal of Medicine, January 30, 1997 (Vol. 336, no. 5, pp. 366-367) By Jerome P. Kassirer, M.D. T

EXECUTIVE SUMMARY

Janet E. Joy, Stanley J. Watson, Jr., and John A. Benson, Jr., Editors Division of Neuroscience and Behavioral Health INSTITUTE OF MEDICINE NATIONAL ACADEMY PRESS Washington, D.C. 1999 Notice | Principal Investigators and Advisors | Reviewers | Preface Acknowledgments | Contents

UNITED STATES DEPARTMENT OF JUSTICE

Judge Young's ruling (Pages 1-15) Judge Young's ruling (Pages 16-34)

Therapeutic Potential and Medical Uses of Marijuana

Psychoactive Drugs, 14 (1982): 239-241 by Todd Mikuriya, M.D. Contents Glaucoma Antiemetic Action

Will IOM Report Encourage Clinical Trials?

The Scientist , May 10, 1999 By Peter Gwynne A s an issue on the cusp of science and

The Therapeutic Effects of Cannabinoids

From The Health and Psychological Consequences of Cannabis Use, Australian National Drug Strategy Monograph Series No. 25 (1994) By Wayne Hall, Nadia Solowij and Jim Lemon, National Drug and Alcohol Research Centre

CANNABIS SATIVA (Ta-ma)

From Chinese Medicinal Herbs (Georgetown Press, San Francisco, 1973) Compiled by Li Shih-Chen, Translated and Researched by F. Porter Smith, M.D. and G.A. Stuart, M.D.

Testimony of Lester Grinspoon, M.D.

Associate Professor of Psychiatry, Harvard Medical Schoolbefore the Crime Subcommittee of the Judiciary Committee, U.S. House of Representatives, Washington, D.C., October 1, 1997 M r. Chairman and members of the subcommittee, I appreciate the opportunity to appear before you this morning to shar

Reefer Madness

New England Journal of Medicine, August 7, 1997 By George J. Annas Introduction Marijuana is unique among illegal drugs in its
Movement Disorders

Open Label Evaluation of Cannabidiol in Dystonic Movement Disorders

International Journal of Neuroscience, 1986, Vol. 30, pp. 277-282 By Paul Consroe, Reuven Sandyk and Stuart R. Snider Department of Pharmacology and Toxicology, and Neurology University of Arizona M

Anticonvulsant Nature of Marihuana Smoking

Journal of the American Medical Association, October 20, 1975, Vol 234, No 3: 306-307 By Paul Consroe, PhD: George C. Wood, PhD; Harvey Buchsbaum, MD From the departments of pharmacology (Dr. Consroe) and

Hypnotic and Antiepileptic Effects of Cannabidiol

Journal of Clinical Pharmacology, 1981; 21: 417S-427S By Elisaldo A. Carlini, M.D., and Jomar M. Cunha, M.D. Department of Psychobiology, Escola Paulista de Medicina, Sao Paulo, Brazil.

Letters to Nature

84 NATURE | VOL 404 | 2 MARCH 2000 | www.nature.com 6. Pantev, C. et al. Relationship of transient and steady-state auditory evoked ®elds. Electroenceph. Clin. Neurophysiol. 88, 389±396 (1993). 7. Hari, R. HaÈmaÈlaÈinen, M. & Joutsiniemi, S. -L.

Effects of Cannabidiol in Huntington's Disease

Neurology 36 (Suppl 1) April 1986 p. 342 By Reuven Sandyk, Paul Consroe, Lawrence Z. Stern, and Stuart R. Snider, Tucson, AZ Abstract: Cannabidiol (CBD) is a major
HIV/AIDS

HIV and Longevity: Cannabis and Lifestyle

Paper by Carol de Launey presented at the 8th International Conference on the Reduction of Drug Related Harm, March 24 - 27, 1997, Paris, France , By Carol de Launey INTRODUCTION HIV-positive gays may be more likely to use cannabis than HIV-negative gays (Wod
Cancer

Amelioration of Cancer Chemotherapy-Induced Nausea and Vomiting by Delta-9-Tetrahydrocannabinol

The Medical Journal of Australia , 1979 By Ekert, H., K.D. Waters, I.H. Jurk, J. Mobilia, and P. Loughnan. N ote: charts and graphs have not been included with this docum

The Use of Inhalation Marijuana as an Antiemetic for Cancer Chemotherapy

New York State Journal of Medicine, October 1988, pp. 525-527 By Vincent Vinciguerra, MD; Terry Moore, MSW; Eileen Brennan, RN From the Don Monti Division of Oncology, Department of Medicine, North

Marijuana as Antiemetic Medicine: A Survey of Oncologists' Experiences and Attitudes (Journal of Clinical Oncology, Vol. 9(7) (1991): 1314-1319.)

Journal of Clinical Oncology, Vol. 9(7) (1991): 1314-1319. By Doblin, Richard E. and Mark A. R. Kleiman.

Delta-9-Tetrahydrocannibinol as an Antiemetic in Cancer Patients Receiving High-Dose Methotrexate

Annals of Internal Medicine, December 1979; 91: 819-824 ALFRED E. CHANG, M.D.; DAVID J. SHILING, M.D.; RICHARD C. STILLMAN, M.D.; NELSON H. GOLDBERG, M.D.; CLAUDIA A. SEIPP, R.N

Antiemetics in Patients Receiving Chemotherapy for Cancer

New England Journal of Medicine, Vol. 302(3) (1980): 135-138 By Sallan, Stephen E., Carol Cronin, Marvin Zelen, and Norman E. Zinberg

An Efficient New Cannabinoid Antiemetic in Pediatric Oncology

Life Sciences, 56(23/24); 2097-2102 Aya Abrahamov 1 , Avraham Abrahamov 2 and R. Mechoulam 3 1 Department of P

Anticancer Activity of Cannabinoids

Journal of the National Cancer Institute, Vol. 55, No. 3, September 1975, pp.597-602 By A.E. Munson, L.S. Harris, M.A. Friedman, W.L. Dewey, and R.A. Carchman Department of

New, Improved Medical Marijuana Drug Readied for Testing

Oncology Times, May 1998 (Volume XX, No. 5) p. 75 By Peggy Eastman Washington, DC - The company that makes Marinol - the only medicinal marijuana drug approved in the U
Glaucoma

Effect of Marihuana on Intraocular and Blood Pressure in Glaucoma

Ophthalmology, March 1980, Vol. 87, No. 3, pp. 222-228. By John C. Merritt, MD, William J. Crawford, PhD, Paul C. Alexander, MD, Alfred L. Anduze, MD, Solomon S. Gelbart, MD
Migraines

Cannabinoids Block Release of Serotonin from Platelets Induced by Plasma from Migraine Patients

International Journal of Clinical Pharmacology. Res V (4) 243-246 (1985) By Volfe Z., Dvilansky A., Nathan I. Blood Research, Faculty of Health Sciences, Soroka Medical
Asthma

Acute Effects of Smoked Marijuana and Oral Delta-9-tetrahydrocannabinol on Specific Airway Conductance in Asthmatic Subjects

American Review of Respiratory Disease, Volume 109, 1974, p. 420-428 By Donald P. Tashkin, Bertrand J. Shapiro, and Ira M. Frank SUMMARY: The acute effects o
Head Trauma

Synthetic Marijuana Helps Trauma Patients

Associated Press, October 9, 1998 SEATTLE -- Marijuana can get you high but won't help you much if you're knocked unconcious. Now, a synthetic "mirror image" of marijuana's active agent wo

Cannabinoid is Neuroprotective in Head Trauma

The Lancet, November 7, 1998 By Rachelle H B Fishman The leading cause of death among young men in the western world--sequelae of severe head traum

New Drug for Brain Injury

“Head injury treatment is one of the biggest medical unmet needs there is, so this is potentially a billion-dollar drug.” — Haim Aviv, CEO of drug maker Pharmos
Mental Illness

Effects of Cannabidiol in Animal Models Predictive of Antipsychotic Activity

Psychopharmacology (1991) 104: 260-264 A.W. Zuardi, J. Antunes Rodrigues, and J.M. Cunha School of Medicine of Ribeirao Preto, USP, 14049 Ribeirao Preto, SP, Brazil School of Medicine, UF, 38400

Are People With Schizophrenia Drawn To Smoking Pot?

New Scientist , May 29, 1999 By Jonathan Knight, San Francisco A compound related to the active ingredient in marijuana may be accumulating in the
Old Age

Marijuana Chemical Tapped to Fight Strokes

Science News, July 11, 1998 (Vol. 154, No. 2, p. 20 By J. Brainard The breakfast table may someday feature not only orange juice and vitamins but also a more exotic hea

Marijuana: An Herb for the Aging

From Marijuana: Cultivator's Handbook (Berkeley: And/Or Books, 1986) By Bill Drake O ne of the groups most deprived by marijuana's illegal status is the aged b